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a b s t r a c t
Vampire bat rabies is a public and animal health concern throughout Latin America. As
part of an ecological study of vampire bat depredation on cattle in southern Guatemala,
we conducted a vaccine seroconversion study among three dairy farms. The main objectives of this cross sectional and cohort study were to understand factors associated with
bat bites among cattle, to determine whether unvaccinated cattle had evidence of rabies
virus exposure and evaluate whether exposure was related to bat bite prevalence, and to
assess whether cattle demonstrate adequate seroconversion to two commercial vaccines
used in Guatemala. In 2012, baseline blood samples were collected immediately prior to
intramuscular inoculation of cattle with one of two modiﬁed live rabies vaccines. Post vaccination blood samples were collected 13 and 393 days later. Sera were tested for rabies
virus neutralizing antibodies (rVNA) by the rapid ﬂuorescent focus inhibition test (RFFIT).
Across two years of study, 36% (254/702) of inspected cattle presented gross evidence of
vampire bat bites. Individual cattle with a bat bite in 2012 were more likely have a bat
bite in 2013. Prior to vaccination, 12% (42/350) of cattle sera demonstrated rVNA, but bite
status in 2012 was not associated with presence of rVNA. Vaccine brand was the only factor associated with adequate rVNA response of cattle by day 13. However, vaccine brand
and rVNA status at day 13 were associated with an adequate rVNA titer on day 393, with
animals demonstrating an adequate titer at day 13 more likely to have an adequate titer
at day 393. Our ﬁndings support stable levels of vampire bat depredation and evidence of
rVNA in unvaccinated cattle. Brand of vaccine may be an important consideration impacting
adequate rVNA response and long-term maintenance of rVNA in cattle. Further, the results
demonstrate that initial response to vaccination is associated with rVNA status over one
year following vaccination.
Published by Elsevier B.V.
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1. Introduction
Rabies is caused by infection with negative sense single stranded RNA viruses in the genus Lyssavirus. Rabies
virus is the most relevant member from an epidemiological perspective, due to an estimated global human burden
in excess of 55,000 cases annually (Knobel et al., 2005).
While the global human burden is principally associated
with transmission cycles involving domestic dogs, bats are
an important reservoir and vector of rabies in the Americas. Rabies outbreaks in cattle have been reported since the
early 20th century (Carini, 1911; Haupt and Rehaag, 1921).
Carini (1911) linked the outbreaks in cattle to wildlife, as
cases in dogs were rare at that time and canine population reduction had no effect on the incidence of cases in
cattle. Haupt and Rehaag (1921) were able to isolate the
virus from a fruit bat (Artibeus lituratus), providing the
ﬁrst evidence linking rabies in cattle with bats. However,
it was not until an outbreak in Trinidad that rabies virus
(RABV) was isolated from several naturally infected common vampire bats (Desmodus rotundus) and linked to the
disease in cattle and man (Pawan, 1936). Thereafter, cattle
rabies was widely recognized in Latin America, with estimated annual mortality of 0.5 million cattle and annual
economic losses of $47 million 1967 USD (∼$335 million 2014 USD; www.bls.gov) despite estimated annual
vaccination of 2.7 million cattle (Acha, 1967). Cattle continue to be the primary sentinel animal associated with
RABV circulation in vampire bats and outbreaks throughout Latin America. One study from Mexico demonstrated
a mean mortality rate of 10.3% among affected herds with
50 or more animals, with a range of 1.3% to 29% (Prieto
and Baer, 1972). As vaccination campaigns have reduced
the burden of canine rabies in Latin America, D. rotundus has become the primary reservoir and vector of rabies
(Schneider et al., 2009). These obligate blood feeders prefer cattle as a prey resource (Greenhall, 1988), though there
can be dietary ﬂexibility where cattle are scarce (Delpietro
et al., 1992).
Experimental evidence supporting the utility of vaccination to protect cattle against bat rabies appear as
early as 1955 (Carneiro et al., 1955), and modiﬁed live or
nervous tissue vaccines were shown to reduce mortality
of cattle on affected farms during outbreaks (Prieto and
Baer, 1972). However, vaccination coverage among cattle,
as a preventative measure against rabies infection, tends
to be low (<5%) throughout most of Latin America (OIE,
2013), likely due to the relatively high cost of vaccinating large numbers of animals, turnover in herd animals
across years, and low perceived threat of rabies among
farmers. In Guatemala, the cattle population reported to
OIE from 2005 to 2012 ﬂuctuated between 2.0 and 4.5 million animals, with highest estimate in 2009 and lowest
in 2012 (OIE, 2013). During all years except 2009, vaccination coverage was estimated to be between 0 and 2%
of the cattle population. In 2009, 0.5 million doses were
administered to cattle and coverage was estimated to be
11% of the cattle population. A recent study from Mexico
has demonstrated that pre-exposure vaccination of cattle
may be more efﬁcient and economically beneﬁcial than
control efforts focused on depopulation of vampire bats
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(Anderson et al., 2012). However, even if rabies risk was
removed from the equation, the secondary infections that
commonly result from vampire bat depredation still poses
a serious economic hardship for farmers in lost production
value of affected herds (Flores-Crespo and Arellano-Sota,
1991).
Historically in Guatemala, livestock farming was most
proliﬁc in the southeastern region of the country. However, an increase in sugar cane and rubber production in
the southeastern region has spurred signiﬁcant land use
conversion, and livestock farming and the associated burden of rabies has primarily shifted to the northwestern
region of the country, though smaller dairy operations
remain active in the southeast. While the number of rabies
cases in dogs in Guatemala appears to be declining, the
number of cases in cattle has been rising steadily over
the past decade (OIE, 2013), though the impact of testing
effort is unclear due to the absence of reported denominator data. As virus typing is not performed on positive
cases, it has not been possible to link the rise in cattle
cases with vampire bat rabies. However, this scenario is
most likely given the strong association of vampire bats
with cattle rabies outbreaks elsewhere throughout Latin
America and the high number of cattle cases and rare
occurrence of canine cases in some Departments (e.g.,
Petén, Alta Verapaz). Despite a lack of conclusive laboratory evidence linking rabies in cattle to bats, vampire
bat control activities (i.e., poisoning or culling) are conducted in Guatemala in response to suspected outbreaks
in cattle, although these are reactive strategies and sporadically applied. While they may eliminate local colonies
of bats, and reduce bite incidence to cattle within a short
time frame, these strategies are ineffective at controlling
rabies virus circulation in vampire bats at a landscape scale.
Thus, vaccination is necessary to protect livestock against
rabies infection. During past suspected outbreaks, mass
vaccination of cattle was initiated with assistance from
the Ministry of Agriculture (MAGA), but suspect clinical
cases of rabies in vaccinated cattle have raised concerns
about the efﬁcacy of the vaccines used – as reported elsewhere (Oliveira et al., 2000). There are several possibilities
regarding such cases, including scenarios that animals are
incubating the disease prior to vaccination, that the vaccine
was improperly stored or administered, that the animal
did not actually die of rabies (i.e., no lab conﬁrmation of
case), or potential for reversion of virulence of the modiﬁed live vaccine (Whetstone et al., 1984). One recent
paper has highlighted the complexity of diagnosing rabies
based on clinical signs in areas where other neurologic
diseases of cattle can be present (Ramirez-Romero et al.,
2014).
The objectives of this study were to understand factors associated with bat bites among cattle, to determine
whether unvaccinated cattle had evidence of rabies virus
exposure and evaluate whether exposure was related to bat
bite prevalence, and to assess whether cattle demonstrate
adequate seroconversion to commercial modiﬁed live
rabies vaccines licensed in Mexico and used in Guatemala.
This study compares both the short-term response to two
different rabies vaccines and the maintenance of antibody
titers over one year post vaccination.
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2. Materials and methods
2.1. Animal sampling and treatments
The study design had elements of a cross sectional
and cohort nature. Bat bite prevalence among all animals
inspected at the farms, and seroprevalence of antibodies in
unvaccinated cattle, were investigated in a cross-sectional
design. Bat bite prevalence to individual animals across
years, and antibody response to vaccination, were investigated in a cohort design. Three dairy farms in the
municipality of Patulul, located in the Department of
Suchitepéquez, Guatemala, were enrolled in the vaccination study as a result of ongoing ecological studies of
vampire bats in the same area and capture of bats at or
near some of the farms. Farms were identiﬁed as A, B, and
C (Fig. 1). Each farm has a standing herd ranging from 100
to 200 cattle, and animals are bought, sold, and born in the
herds each year, though the rates of turnover vary across
the farms (e.g., C has the highest turnover rates and A the
lowest). All cattle over six months of age at each farm were
included in the study. Sex ratios in the herds tend to be
heavily skewed to females, with one or two breeding bulls
and a variable number of juvenile males. No animals in
the herds were reported as vaccinated against rabies by
the farm owners prior to the study. Protocols for animal
restraint and sampling were approved by the Centers for
Disease Control and Prevention (USA) and the Universidad del Valle de Guatemala (Guatemala) Animal Care and
Use Committees. During February 7–9, 2012, cattle were
corralled and manually restrained to permit sampling and
vaccination. Cattle were visually inspected to determine
relative age, sex, and gross evidence of vampire bat bites
(e.g., open and/or bleeding lesions approximately 2–3 cm
in diameter). Approximate ages of cattle were available
at farm A, but in other cases relative ages were assigned
such that ‘juvenile’ refers to an animal less than 2 years
of age and ‘adult’ refers to an animal equal to or greater
than 2 years of age. A 3–5 ml blood sample was collected by
venipuncture of the jugular or tail (coccygeal) vein immediately prior to intramuscular vaccination with 2 ml of (one
of two) commercially available modiﬁed live rabies vaccines. Hereafter, these products are referred to as vaccine
‘A’ and vaccine ‘B’ to protect the identity of the manufacturers. Vaccine A is made with the Evelyn Rokitnicki Abelseth
(ERA) strain of rabies virus, and vaccine B is made with the
Street Alabama Dufferin (SAD) strain. Vaccines were reconstituted on site using supplied sterile water according to
the manufacturer’s instructions, and were maintained on
ice packs in a styrofoam cooler until use (i.e., within 6 h
of reconstitution). Both products are licensed in Mexico
and labeled for use in large animals. Animals were arbitrarily assigned to one of the two vaccination treatment
groups during initial sampling, which resulted in greater
treatment applications of vaccine B (NA = 121, NB = 229). No
unvaccinated control animals were assigned or followed in
the study.
Cattle were corralled and manually restrained during
February 20–22, 2012 to collect a 13 day post vaccination blood sample. Farms were sampled in an identical
sequence. No visual inspection of bat bites was performed

during the day 13 follow up visit. During March 5–7, 2013,
393 days after vaccination, cattle were again corralled and
manually restrained for collection of a blood sample prior
to booster vaccination with 2 ml of vaccine B. Selection of
vaccine B for booster vaccination was due to constraints
of product availability from the Guatemalan supplier of
vaccine A at the time of booster vaccination. During
2013 sampling, cattle were visually inspected to determine relative age, sex, and gross evidence of vampire bat
bites.
At farm A, cattle were identiﬁed by permanently
branded numbers, providing a unique and consistent form
of identiﬁcation. At farm B, cattle were identiﬁable by
name, providing a unique and consistent form of identiﬁcation. At farm C, 25 [milk] cattle were identiﬁable by
name, and temporary chemical brands of a two or threedigit unique number were applied to all other farm C cattle
by MAGA personnel during the initial sampling in 2012.
Long-term re-sampling was not initially anticipated during
activities in 2012. While it was possible to read the chemically branded numbers of farm C cattle at 13 days post
vaccination, it was no longer possible to read the numbers at 393 days post vaccination. Due to this factor, and
because it was not possible to re-sample the 25 cattle identiﬁed by name in 2013, farm C cattle were excluded from
day 393 analyses. Other animals lost during follow up were
necessarily excluded from day 13 or day 393 analyses.
Blood samples were kept out of direct sunlight during
sampling, and within 10 h of collection they were separated
by low-speed centrifugation for 10 min. Sera were transferred into 2 ml cryovials using sterile pipettes, and stored
at −70 ◦ C until shipment to the Rabies Laboratory at CDC in
Atlanta, GA, USA.
2.2. Detection of rabies virus neutralizing antibodies
Sera were assayed for rabies virus neutralizing antibodies (rVNA) by rapid ﬂuorescent focus inhibition test (RFFIT)
as described by Smith et al. (1996), and screened at 1:5 and
1:25 dilutions. Raw titers were converted to international
units (IU) by comparison to the positive control standard
rabies immune globulin (SRIG) containing 2 IU/ml, evaluated in each test in ﬁve-fold dilutions up to 1:625. The
cut-off threshold for seropositive rVNA status was taken as
100% neutralization of virus at a 1:5 serum dilution, corresponding to titers equal to or greater than 0.10 IU/ml.
The threshold for adequate rVNA response was taken as
50% or greater neutralization of virus at a 1:25 serum dilution, which corresponded to titers equal to or greater than
0.20 IU/ml. All positive sera (i.e., titer greater than or equal
to 0.10 IU/ml) were tested in duplicate or triplicate, and
geometric mean titers were used for the ﬁnal evaluation in
relation to the cut-offs.
2.3. Statistical analyses
Contingency analyses were used to evaluate variation in
bite prevalence among all cattle at farms A, B and C during
2012 and 2013. Generalized linear mixed models (GLMs) of
a logistic nature were used to test for associations with ﬁve
binomial response variables. Farm was treated as a random
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Fig. 1. Map of the study area and departments of Guatemala. The map inset is the municipality of Patulul, located in the Department of Suchitepéquez.
Solid circles show the locations of the three farms in the study.

effect in all GLMs to permit generalizing the results of this
study and to control for confounding effects of farm variation on certain ﬁxed effect variables. Fixed effects in the
GLMs were binary, and included sex (male/female), relative
age (adult/juvenile), rVNA status (0/1), bite status (0/1), and
vaccine brand (A/B). Due to uneven sampling of relative age
and sex, an interaction term was included in GLMs where
applicable. For repeat observations of an individual animal,
a factor of the earlier status of the individual was included
as a ﬁxed effect in the GLM to account for prior observations (e.g., bite or antibody status). Continuous age data
measured in years were available from cattle at farm A, and
logistic GLMs with age as the only ﬁxed effect were tested

against response variables of interest when untreated or
log-transformed age data were normally distributed. When
untreated or log-transformed age data from farm A were
not normally distributed, a nonparametric ANOVA on the
ranks was used to test for an association of the response
variable with age. Pending the results of logistic GLMs using
a single ﬁxed effect of age, multiple ﬁxed effects were tested
with farm A data to evaluate the effect of age while controlling for other binary variables described above. Logistic
GLMs (PROC GLIMMIX) and other analyses were run using
SAS v9.2 (SAS Institute, Cary, NC). Estimates and standard
error for farm, the random effect covariance parameter, are
shown for each mixed GLM evaluated. Odds ratios (OR)
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Table 1
Demographic data for the cohort of cattle sampled at three farms in 2012 and re-sampled in 2013.
Farm

2012

2013

Adults

Juveniles

Total

Adults

Male

Female

Male

Female

Male

A
B
C

1
3
4

154
94
52

0
0
26

0
25
34

155
122
116

1
2
0

Total

8

300

26

59

393

3

Juveniles
Female

Total

Male

Female

81
73
0

0
0
0

0
5
0

82
80
0

154

0

5

162

Table 2
The number of cattle inspected and proportion demonstrating evidence of bat bites during cross sectional surveys in 2012, 2013, and cumulatively at three
farms in Patulul, Guatemala.
Farm

2012

2013

Cumulative

N

Proportion with bites

N

Proportion with bites

N

Proportion with bites

A
B
C

155
122
116

0.43
0.09
0.20

115
127
67

0.71
0.31
0.49

270
249
183

0.55
0.20
0.31

Total

393

0.25

309

0.50

702

0.36

were calculated for signiﬁcant ﬁxed effects (˛ = 0.05), with
95% conﬁdence limits.
3. Results

Table 3
A description of generalized linear mixed models evaluated in the cohort
study. Farm was treated as a random effect in each model. Fixed effects in
bold text were signiﬁcant for a given model.
Model

A total of 393 cattle were sampled and vaccinated during
the initial visit in 2012 (Table 1). Based on unique permanent identiﬁcation present at farms A and B in 2012,
it could be determined that 58% of 277 cattle sampled from
those two farms were resampled in 2013. Due to temporary
chemical brand identiﬁcation applied to cattle at farm C in
2012, and inaccessibility of the uniquely named farm C cattle in 2013, it was not possible to determine whether any of
the 116 cattle sampled at farm C in 2012 were resampled
in 2013.
3.1. Bat bite prevalence among cattle
Prevalence of bat bites among cattle at the farms varied between years (Table 2). Bite prevalence across farms
varied in 2012 (2 = 43.3, P < 0.0001) and in 2013 (2 = 39.8,
P < 0.0001) (Table 2). In comparisons of cross-sectional bite
data from 2012 to 2013 (Table 2), year was associated
with bite prevalence (year F1,698 = 53.4, P < 0.0001, OR 3.7
[95% CL 2.6–5.3], farm 0.83 ± 0.86) and cattle in 2013 were
more likely to be bitten. In the 2012 cohort, sex was the
only factor associated with bite status and males were
more likely to be bitten compared to females (Table 3,
Model 1; sex F1,387 = 4.3, P = 0.04, OR 3.0 [95% CL 1.1–8.7],
farm = 1.13 ± 1.20). From the 2012 cohort, 162 cattle were
re-inspected in 2013 (Table 3, Model 2). Animals bitten in
2012 were more likely to have evidence of bites in 2013
(2012 bite status F1,159 = 9.5, P = 0.002; OR = 4.0 [95% CL
1.6–9.5], farm = 0.88 ± 1.34).
In the farm A cross sectional data from 2012 to
2013 (Table 2), neither age nor log-transformed age
data were normally distributed. Although none of the
farm A cattle sampled were juveniles (range2012 : 2–16
years, median2012 = 7.5 years; range2013 : 2.5–17 years,

N

Response variable

Predictors of bite status
393
2012 bite status
(1)
(2)

162a,b

2013 bite status

Fixed effects
Relative age, sex,
relative age × sex
2012 bite status

Predictors of rVNA in unvaccinated animals
350
Day 0 rVNAc
Relative age, sex, 2012
(3)
bite status
Predictors of response to rabies vaccination
318
Day 13 rVNAd
Relative age, sex, 2012
(4)
bite status, vaccine
brand, day 0 rVNA
status, relative
age × sex
(5)
133a,b
Day 393 rVNAd
2013 bite status,
vaccine brand, day 0
rVNA status, day 13
rVNA status
a
b
c
d

Less than ﬁve males sampled; sex not included.
Five juveniles sampled total; relative age not included.
Evaluated at rVNA greater than or equal to 0.10 IU/ml.
Evaluated at rVNA greater than or equal to 0.20 IU/ml.

median2013 : 7 years), age was associated with bite status
in the cross sectional 2012 data and younger animals were
more likely to be bitten in a nonparametric ANOVA on the
ranks (F1,142 = 12.4, P = 0.0006). In the cross sectional data
from farm A in 2013 (n = 115), a similar trend was observed
with younger animals more likely to be bitten in a nonparametric ANOVA on the ranks (P = 0.09).
3.2. Rabies antibodies in unvaccinated cattle
Among 393 cattle sampled prior to vaccination in 2012,
rVNA titers were determined from 89% of 393 animals.
Of 350 cattle sera tested, 12% of sera presented evidence of rVNA prior to vaccination (Table 4). The rVNA
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Table 4
The proportion of cattle in the cohort study with pre and post vaccination rabies virus neutralizing antibody titers of cattle at three farms in Patulul,
Guatemala.
Farm

A
B
C
Total
a
b

Day 0

Day 13

Day 393

N

≥0.10

N

≥0.10

≥0.20

≥0.10

≥0.20

114
120
116

0.06
0.04
0.26

102
111
73

0.57
0.61
0.67

0.40
0.47
0.49

54
71
0

0.24
0.31
–

0.13
0.20
–

350

0.12

286

0.61

0.45

125

0.28

0.17

a

b

a

Nb

Rabies virus neutralizing antibody titer cut-off (IU/ml).
Includes only animals seronegative at baseline (day 0).

seroprevalence in unvaccinated cattle varied across farms
(2 = 31.8, P < 0.0001), with farm C (26%) having higher antibody prevalence compared to farm A (6%) and farm B (4%).
However, the presence of rVNA in unvaccinated cattle was
not associated with the animal’s bite status in 2012, sex nor
relative age (Table 3, Model 3; farm = 1.01 ± 1.13). Among
cattle sera tested at the farm A, log age data were normally
distributed, but the presence of rVNA in unvaccinated cattle
was not associated with log age.
3.3. Antibody response of cattle to vaccination
Day 13 post vaccination rVNA titers were determined
from 318 cattle with a known baseline titer (Table 4).
Among cattle that were rVNA negative prior to vaccination and sampled at day 13 (n = 286), 45% demonstrated
an adequate rVNA response 13 days post vaccination
(i.e., titer ≥ 0.20 IU/ml), whereas 61% were rVNA seropositive (i.e., titer ≥ 0.10 IU/ml). Among cattle that were rVNA
seropositive prior to vaccination and sampled at day 13
(n = 32), 59% demonstrated an adequate rVNA response 13
days post vaccination, whereas 78% were rVNA seropositive. Among all 318 cattle with sera evaluated at day 0 and
day 13 post vaccination (Table 3, Model 4), vaccine brand
was the only factor associated with an adequate rVNA
response at day 13 (vaccine brand F1,309 = 24.0, P < 0.0001,
OR 3.6 [95% CL 2.2–6.0], farm = 0.06 ± 0.12), and cattle
treated with vaccine A were more likely to demonstrate an
adequate titer by day 13 compared to cattle treated with
vaccine B. An adequate response by day 13 was marginally
associated with baseline rVNA status (P = 0.08), and cattle
seropositive at baseline were more likely to demonstrate
an adequate rVNA response by day 13. An adequate rVNA
response at day 13 was not associated with relative age,
sex, a relative age by sex interaction term, nor 2012 bite
status. Among cattle at farm A with titers evaluated at day
0 and day 13 post vaccination, log age data were normally
distributed, but an adequate rVNA response was not associated with log age.
Among cattle that were seronegative prior to vaccination in 2012 and sampled at days 13 and 393 (n = 125), 17%
demonstrated an adequate rVNA titer at day 393, whereas
28% were seropositive (Table 4). Among cattle that were
seropositive prior to vaccination in 2012 and sampled at
days 13 and 393 (n = 8), 13% demonstrated an adequate
rVNA titer at day 393, whereas 63% were seropositive.
Among cattle sampled longitudinally across all time points
(Table 3, Model 5), vaccine brand (vaccine brand F1,127 = 6.0,

P = 0.02, OR 3.6 [95% CL 1.3–10.4]) and rVNA status at day
13 post vaccination (day 13 status F1,127 = 7.6, P = 0.007, OR
4.4[95% CL 1.5–12.8]) were associated with an adequate
rVNA titer at day 393 post vaccination (farm = 0.40 ± 0.81).
Similar to the day 13 results, cattle that received vaccine A
were more likely to have an adequate rVNA titer at day 393.
Cattle which demonstrated an adequate rVNA titer at day
13 post vaccination were more likely to have an adequate
titer at day 393. Cattle with evidence of a bat bite in 2013
were marginally more likely to have an adequate rVNA titer
at day 393 (P = 0.10). Baseline rVNA status was not associated with an adequate rVNA response at day 393. At farm
A, log age data were normally distributed, but an adequate
rVNA response at day 393 was not associated with log age.
4. Discussion
Vampire bat depredation is a well-recognized public
and veterinary health concern throughout Latin America,
and the risk of rabies, a highly fatal zoonosis, is clearly
the most high proﬁle infection risk posed by vampire bat
bites. Other relevant health risks associated with vampire
bat depredation of cattle include secondary infections that
result from the open wounds left by bats after feeding,
although data on lost production value due to blood loss
alone have been equivocal (Flores-Crespo and ArellanoSota, 1991). Despite this, relatively low proportions of
farmers in Latin America vaccinate their cattle against
rabies. Literature has suggested that vampire bats may be
loyal to stable and reliable food sources (de Verteuil and
Urich, 1936). While the feeding behaviors of individual
vampire bats were not monitored during the study period,
individual bat ﬁdelity to foraging grounds (i.e., cattle pastures) was observed during a three week radiotracking
study in 2011 at the farm A involving 16 D. rotundus (AG,
unpublished data). Vampire bat roosts (est. 20–50 bats)
were visually located within 2 km proximity to farms A and
C during 2012, but no bat roost was visually located in proximity to B. The results of the current study demonstrate
nonrandom attacks on cattle across years, where certain
cattle suffer repeated depredation by vampire bats over
time. Where approximate cattle ages were known at farm
A, younger cattle were more likely to be bitten compared
to older cattle, although all farm A cattle sampled were
considered adults.
Despite the relatively high prevalence of vampire bat
bites on cattle during the two-year study period, it is
equally noteworthy that only two cases of cattle rabies
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were reported to OIE during 2005–2012 from the Department of Suchitepéquez (one in 2010, one in 2011), whereas
102 cases of cattle rabies were reported from the northern Department of Petén and 50 cattle cases reported
from the northern Department of Alta Verapaz during
the same time period (OIE, 2013). While geographic
area or population size of the Departments may be a
factor (Fig. 1), area-corrected cattle rabies incidence is
still three to six times as high in the northern Departments of Petén (2.8 × 10−3 cases/km2 ) and Alta Verapaz
(5.1 × 10−3 cases/km2 ) in comparison to Suchitepéquez
(8.3 × 10−4 cases/km2 ). The population corrected incidence, using the average projected population from 2005
to 2010 of the three Departments (I.N.E., 2008), shows similar trends (Petén – 10 cases per 100,000 pop, Alta Verapaz
– 9 cases per 100,000 pop, Suchitepéquez – 0.42 cases
per 100,000 pop). However, during the same time period,
45 cases of dog rabies were reported from Suchitepéquez,
in contrast to two dog cases from Alta Verapaz and ﬁve
dog cases from Petén, suggesting that canine rabies is of
greater concern in the southwestern Departments. As a
result, we cannot rule out that some rabies virus exposures
in unvaccinated cattle that were detected in this study
might also be due to contact with dogs, although the ecological link with vampire bats is clearly stronger. Despite
this, reports of cattle rabies in Guatemala appear to be on
the rise in recent years, though a lack of variant typing has
precluded direct association with vampire bat RABV, and
the absence of reported rabies cases in bats leaves many
questions. A low proportion of clinically suspect cattle are
subject to diagnostic testing by the national laboratories
in Guatemala, primarily due to difﬁculties with sample
transport and cold chain maintenance, as likely occurs elsewhere in Latin America (Baer, 1991). Thus, the current
passive surveillance system underestimates the true burden of cattle rabies in the country. Although independent
surveillance of bats in this study area (i.e., at farm A) did
not provide serologic evidence of rabies virus circulation
in 2011, there is strong evidence of rabies virus circulation
among bats in nearby localities based on rVNA seroprevalence and virus isolation (Ellison et al., 2014). The detection
of rVNA in unvaccinated cattle suggests prior exposure of
cattle to RABV in the study area, and may be associated with
the repeated vampire bat depredation as observed during
the study. None of the cattle were reported by farm owners
to have been vaccinated prior to the study and, with a single exception (i.e., the bull), all animals sampled at farm A
were born and raised on that farm. It is unclear why there
were lower proportions of unvaccinated cattle with rVNA
detected in 2012 at farms A (6%) and B (4%) compared to
farm C (26%), but an unrecognized history of vaccination
may have been possible at farms B and C. However, at farm
A, where animal records, identiﬁcation and animal retention were highly reliable, we can conﬁrm that all seven
unvaccinated animals with rVNA at day 0 had been on that
farm for the past 5–11 years (i.e., since birth).
The rVNA response to vaccination with rabies vaccines is
well studied in livestock (Prosperi et al., 1984; Cortes et al.,
1993; da Silva et al., 2000; Oliveira et al., 2000), and most
prior work has compared responses to live versus inactivated rabies vaccines. An [adjuvanted] inactivated vaccine

produced more robust rVNA responses than a modiﬁed live
vaccine following a single dose regimen in cattle in one
study (Prosperi et al., 1984), but a subsequent study found
weak stimulation of antibodies from a single dose administration of inactivated or modiﬁed live vaccines (Oliveira
et al., 2000). However, stimulation of cell-mediated immunity by [replication of] modiﬁed live vaccines may confer
additional resistance to rabies challenge even where rVNA
induction appears suboptimal. The RABV glycoprotein (G)
is the primary antigen responsible for induction of rVNA
(Wiktor et al., 1973). The peak rVNA response to vaccination with rabies vaccines typically is observed 14–28
days following vaccination, and thus the timing of sampling periods in this study may have precluded detection of
maximal proportions of animals with adequate rVNA, and
potential underestimation of rVNA response to vaccination.
Despite this, an adequate rVNA response was detected on
day 13 in nearly half of the animals, and closer to two-thirds
showed at least some evidence of rVNA seroconversion
on day 13. Although this study did not quantify endpoint
titers to facilitate analysis of an anamnestic response, cattle
that were seropositive prior to vaccination seroconverted
in greater proportions than seronegative cattle.
There was no association of relative age or sex on
the development of an adequate rVNA response by cattle at day 13. Although outside the scope of the current
study, additional investigation is warranted to determine
whether physiological parameters of an animal’s health
could explain the individual variation in serologic response
observed in this study. One potential confounding factor
for the low proportion of study animals with adequate
responses at day 13 may relate to the lack of randomization in the treatment schema, as two-thirds of 393
cattle received vaccine B on day 0. Results unequivocally
indicated an effect of vaccine brand on development of
adequate rVNA among cattle on days 13 and 393 post vaccination. Among 286 cattle seronegative on day 0, 63% of 99
cattle treated with vaccine A had an adequate titer, whereas
36% of 187 cattle treated with vaccine B had an adequate
titer on day 13. Although vaccine B appears to be less
immunogenic to cattle in this study, warranting follow-up
comparative investigations of potency, we cannot conclude
from these data that vaccine B is less efﬁcacious in conferring resistance to RABV infection in vaccinated cattle.
The form of G presentation was found to be an important factor affecting immunogenicity in mice (Dietzschold
et al., 1983). A study in Brazil also demonstrated the importance of the form of G presentation for rVNA response in
cattle, where virion-attached G was the only signiﬁcant
predictor of rVNA response, when compared with total G
or free-soluble G (Piza et al., 2002). The same study also did
not ﬁnd a correlation between vaccine potency, measured
in vivo by the standard NIH (i.e., mouse inoculation) test,
and rVNA induction in cattle (Piza et al., 2002). More laboratory studies of the composition of the vaccines utilized
in this study are needed to understand the variation due to
vaccine brand observed in this study.
Among 133 animals in the study cohort through 2013,
40% of 57 animals with an adequate titer on day 13
were rVNA seropositive over one year later. However, one
confounding factor for the long-term follow up was the
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absence of an unvaccinated seronegative control group to
evaluate the impact of potential natural RABV exposures
from vampire bats or other animals in the study area.
Given the detection of rVNA in unvaccinated cattle and the
marginal association of 2013 bite status with presence of
adequate titers on day 393, natural exposures to RABV from
bat (or dog) bites to cattle may have inﬂuenced rVNA titers
on day 393. The low proportions of animals with adequate
titers at day 13 and over one year later are not surprising
given other studies which have shown weak rVNA response
and maintenance to single doses of modiﬁed live vaccines
(da Silva et al., 2000; Oliveira et al., 2000), and collectively
these studies underscore the importance of annual booster
vaccination. Moreover, rVNA titers may not correlate with
protection against rabies and there is no agreed upon level
deemed protective, as there may be other immunological factors impacting resistance or susceptibility to rabies
(Moore and Hanlon, 2010).
5. Conclusions
Vaccination of incidental hosts such as livestock and
companion animals is a key tool to protect against RABV
infection, especially in areas where there is evidence of
repeated depredation by vampire bats. Given the apparent
rise in signiﬁcance of vampire bat rabies for Latin America as a whole, and as observed from increasing numbers
of laboratory conﬁrmed cases in Guatemala in particular,
the importance of vaccinating valuable production animals
should not be overlooked. Enhanced [active] rabies virus
surveillance among bats in Guatemala also demonstrated
that the risk of RABV infection associated with bats is geographically widespread. The risk of RABV infection is clearly
highest among cattle that are repeatedly bitten by bats,
and in this study bite status in one year was associated
with bite status the following year, although bite status was
not associated with the presence of rVNA in unvaccinated
animals. Vaccine brand was an important factor both in
the initial response and long-term maintenance of an adequate rVNA response, though additional laboratory studies
are needed to understand the basis for these differences.
The initial rVNA response to vaccination was associated
with the long-term maintenance of adequate rVNA titers
in cattle sampled longitudinally. The results of this study
demonstrate that cattle respond to intramuscular vaccination with commercial modiﬁed live vaccines in Guatemala,
and that relative age and sex of the animals are not associated with the initial rVNA response to vaccination.
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